Work

Nonmyeloablative Allogeneic Transplantation in the Imatinib Era: Three Chances To Achieve Molecular Remission in CML.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.1028.1028

Authors: Richard E. Champlin, Sergio Giralt, Elizabeth Shpall, Partow Kebriaei, Paolo Anderlini, Muzaffar Qazilbash, John McMannis, Gloria McCormick, Tobi Fisher, Marcos de Lima, Gabriela Rondon

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589682649

FWCI: 0.212

Cites:

Cited by: 1

Related to: 10